BIOMARIN PHARMACEUTICAL INC (BMRN)
US09061G1013 - Common Stock
ChartMill assigns a Buy % Consensus number of 79% to BMRN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 110.39. This target is 30.51% above the current price.
BMRN was analyzed by 34 analysts. The buy percentage consensus is at 79. So analysts seem to be have mildly positive about BMRN.
In the previous month the buy percentage consensus was at a similar level.
BMRN was analyzed by 34 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-07-25 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2024-07-22 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-06-27 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-05-17 | Baird | Downgrade | Outperform -> Neutral |
| 2024-05-14 | Evercore ISI Group | Initiate | Outperform |
| 2024-04-26 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2024-04-26 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-04-25 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-04-25 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2024-04-25 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-04-25 | Citigroup | Maintains | Neutral -> Neutral |
| 2024-02-29 | Canaccord Genuity | Reiterate | Hold -> Hold |
| 2024-02-23 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-02-23 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2024-02-23 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-01-30 | Baird | Maintains | Outperform -> Outperform |
| 2023-12-21 | Stifel | Reiterate | Buy -> Buy |
| 2023-11-07 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2023-11-03 | BMO Capital | Maintains | Outperform -> Outperform |
| 2023-11-02 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2023-11-02 | Barclays | Maintains | Overweight -> Overweight |
| 2023-11-02 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-11-02 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-10-23 | Bernstein | Upgrade | Underperform -> Market Perform |
| 2023-10-16 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-09-28 | Raymond James | Initiate | Market Perform |
| 2023-09-25 | Truist Securities | Reiterate | Buy -> Buy |
| 2023-09-18 | UBS | Initiate | Buy |
| 2023-09-15 | Truist Securities | Reiterate | Buy -> Buy |
| 2023-09-14 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |